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Abstract
Background: The Blood Brain Barrier (BBB) maintains the homeostasis of central nervous system by preventing the
free passage of macromolecules from the systemic circulation into the brain. This normal physiological function of
the BBB presents a challenge for delivery of therapeutic compounds into the brain. Recent studies have shown
that the application of focused ultrasound together with ultrasound contrast agent (microbubbles) temporarily
increases the permeability of the BBB. This effect is associated with breakdown of tight junctions, the structures
that regulate the paracellular permeability of the endothelial cell layer. The influence of this ultrasound effect on
the activation of intracellular signaling proteins is currently not well understood. Therefore, the aim of this study
was to investigate the activation of cell survival signaling molecules in response to ultrasound-mediated BBB
opening;
Methods: The BBB was disrupted in two four-spot lines (1-1.5 mm spacing) along the right hemisphere of rat brain
with ultrasound beams (0.3 MPa, 120 s, 10 ms bursts, repetition frequency = 1 Hz) in the presence Definity
microbubbles. Contrast-enhanced MRI images were acquired to assess the extent of BBB opening upon which the
animals were sacrificed and the brains removed and processed for biochemical and immunohistochemical
analyses;
Results: Immunoblotting of sonicated brain lysates resolved by SDS-PAGE demonstrated an increase in
phosphorylation of Akt and its downstream signaling molecule, GSK3b, while the phosphorylation of MAPK
remained unchanged. The elevated levels of pAkt and pGSK3b are still evident after 24 hours post-sonication, a
time point where the integrity of the BBB is known to be re-established. Furthermore, immunofluoresence staining
localized this increase in pAkt and pGSK3b levels to neuronal cells flanking the region of the disrupted BBB;
Conclusions: Our data demonstrates that ultrasound-mediated BBB disruption causes an activation of the Akt
signaling pathway in neuronal cells surrounding the disrupted BBB.
Background
The homeostasis of the neuroparanchymal milieu is
controlled by the presence of specialized tight junction
structures existing between endothelial cells of brain
microvessels. These cells are also in close contact with
other cell types of the neural system, including astro-
ctytes, pericytes, microglia and neurons. The complex
signaling and communication which exists amongst
these cell types gives rise to a barrier feature
characterized as the Blood Brain Barrier (BBB). While
the BBB restricts the paracellular translocation of large
hydrophilic macromolecules and toxic compounds into
the brain, there is a diffusion of lipid-soluble small
m o l e c u l e sa sw e l la sf a c i l i t a t e dp a s s a g eo fe s s e n t i a l
nutrients via specific membrane located transport sys-
tems [1-5]. However, the normal functions of the BBB
are disturbed in neuroinflammatory conditions such as
multiple sclerosis, Alzheimer disease (AD), HIV-1 ence-
phalitis, traumatic brain injury, bacterial meningitis,
brain tumors and ischemia/hypoxia [3,6,7].
While the regulation of the BBB function in normal
and physiological conditions is very crucial, it hampers
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any medium, provided the original work is properly cited.the effective delivery of therapeutic agents into the cen-
tral nervous system. As a result, several strategies have
been developed to overcome this impediment. For
instance, intracarotid infusion of hypertonic solutions,
like mannitol, has been shown to increase the perme-
ability of the brain microvessels and promote access of
therapeutic agents to the brain [8,9]. The transport of
drugs from nasal mucosa to brain is another method to
circumvent the BBB. It has been shown that the nasal
cavity provides a special anatomical feature so that
drugs can pass the olfactory epithelium and enter the
central nervous system [10]. Although these modes of
delivery into the brain are effective, they do not result in
a focal disruption of the BBB for the treatment of loca-
lized diseases such as brain cancer.
Recently, it has been shown that the permeability of
the BBB can be locally and temporarily disrupted by
acoustic energy [11-13]. According to these studies, the
application of focused ultrasound in combination with
ultrasound contrast agents, such as Optison, can tem-
porarily increase BBB permeability. As a consequence of
this effect, the chemotherapeutic agents such as doxoru-
bicin and Herceptin, can pass the barrier of endothelial
cells and enter into the brain parenchyma at specific
areas [11,12]. The significance of this method relies on
opening of the BBB at specific locations of the brain
while the rest of the areas remain unaffected.
The cellular and molecular mechanism underlying this
effect is poorly understood. One report suggests that the
oscillation of microbubbles in response to ultrasound
bursts can induce cell membrane deformation and
increase permeability of the endothelial cell monolayer
[14]. In addition to trans-membrane mechanism, there
is also an elevation in paracellular permeability of the
endothelial cells and immunogold electron microscopy
studies attribute this effect to disorganization as well as
a diminished level of tight junction proteins occludin,
claudin5 and ZO-1 [15]. Occludins and claudins are
integral membrane tight junction proteins and their
extracellular regions interact in a homotypic manner
between two adjacent endothelial (or epithelial) cells.
The intracellular domain of these proteins interact with
cytoplasmic membrane-associated tight junction pro-
teins called zonula occludens (ZO proteins), which act
as a bridge between integral membrane proteins and the
actin cytoskeleton [1,5]. As a result, any extracellular or
intracellular signal imposed upon either the elements of
tight junction or cytoskeletal proteins can have an effect
on the integrity, tightness and assembly of the endothe-
lial junctions and eventually the BBB [1,3]. To date, sev-
eral cell signaling pathways, including MAPK and
PI3kinase/Akt, are shown to play a role in regulation of
brain endothelial cell permeability. It has been reported
that reactive oxygen species (ROS) can alter the
cytoskeletal as well as tight junctional organization via
activation of PI3-kinase and Akt [16]. VEGF- and
hypoxia-induced hyperpermeability of brain endothelial
cells is also mediated by activation of PI3-Kinase [17].
Activation of MAPK signaling also contributes to the
BBB opening in several pathological conditions like AD,
focal ischemia and reperfusion, traumatic brain injury
and subarachnoid hemorrhage (SAH) brain injury
[18-20]. In vitro studies also show that H2O2-mediated
increased paracellular permeability in hypoxia/reoxy-
genation is mediated by activation of p44/42 MAPK
[21]. In addition to endothelial cells, PI3kinase/Akt and
MAPK signaling play a role in regulating neuronal cells
survival during pathological insults to the brain and dis-
ruption of the BBB. For example, it has been shown that
phosphorylation of Akt after stroke results in neuronal
survival [22]. The well-known vascular permeable factor
or VEGF is known to increase the BBB permeability and
enhances neuronal protection, the effects of both
mediated by increased PI3-kinase/Akt activity [23].
Moreover, Neuroprotective effect of some hormones
and peptides are mediated via increased phosphorylation
and activation of p44/42 MAPK [24-27]. In contrast to
p44/42 MAPK, increased phosphorylation and activation
of p38 and c-Jun N-terminal kinase (JNK) members of
MAPK promote the apoptosis of cerebella neurons
[28-31].
To date there is no data available on the effect of
ultrasound on cell signaling pathways in brain endothe-
lial and neuronal cells. Therefore the aim of this study
is to investigate the alteration in PI3kinase/Akt and
MAPK signaling pathway in the context of focused
ultrasound-mediated BBB opening.
In the following study we show that the application of
focused ultrasound in combination with ultrasound con-
trast agent disrupts the BBB integrity, and that this dis-
ruption is associated with reduced interaction of the
tight junction protein occludin with ZO-1. Furthermore,
there is an increase in the activity of Akt signaling upon
ultrasound exposure. The Akt signaling remains active
even after 24 hours post-sonication, when the BBB
integrity is re-established. Immunofluorescent micro-
scopy demonstrates that the elevated pAkt as well as
pGSK3b phosphorylation could be attributed to neuro-
nal cells. In contrast to Akt signaling, ultrasound has no
effect on the activity of MAPK pathway.
Materials and Methods
Animal Procedures
All animal experiments were performed on a total of 20-
25 adult male Sprauge-Dawley rats weighing between
300-400 g and the procedures were approved by Animal
Committee at our institution. Animals underwent
anesthesia using a mixture of 50 mg/kg ketamine and
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was removed using depilatory lotion and a catheter was
inserted into the tail vein of each rat. For macroscopic
visualization of BBB opening, animals were injected with
Evans Blue dye (500 μl of 2%) post-sonication.
Ultrasound
The focused ultrasound system was placed inside a 1.5T
MRI scanner (Signa, GE Healthcare, USA) that was used
to image the brain and target the ultrasound beam. The
ultrasound beam was generated by a piezoelectric trans-
ducer (10 cm diameter, 8 cm radius of curvature, 0.558
MHz resonant frequency, manufactured in house) posi-
tioned inside a degassed water tank using an MRI-com-
patible three-axis motorized system (Chopra et al., 2009).
The transducer was driven by a function generator
(Model 395, Wavetek, San Diego, CA, USA) and RF
amplifier (model 240L, ENI Inc, Rochester, NY, USA).
The electrical power was measured with a power meter
(model 438A, Hewlett Packard, Palo Alto, CA, USA) con-
nected to the forward and reserve signal of a dual direc-
tional coupler (C173, Werlatone, Brewster, NY, USA).
The transducer’s electrical impedance was matched to
the output impedance of the amplifier (50Ω)w i t hac u s -
tom-made passive matching circuit. The transducer was
calibrated using a radiation force method for the acoustic
power and calibrated hydrophone for the acoustic pres-
sure amplitude. Four spots, 1.5 mm apart, along the right
hemisphere were targeted with ultrasound (0.3 MPa, 120
s, 10 ms bursts, repetition frequency = 1 Hz). Two four-
spot lines (1-1.5 mm spacing) were applied to cover most
of the area of the right hemisphere. Definity microbub-
bles (20 μl/kg, Lantheus Medical Imaging, USA) was
injected simultaneous to the start of the sonication.
MRI
Anatomical images were acquired in multiple planes prior
to and after sonication using a T2-weighted sequence
(Fast Spin Echo (FSE) sequence: TE = 75 ms, TR = 2000
ms, ETL = 4, BW = 6.9 kHz, 256 × 256/128 × 128, slice =
1 mm, NEX = 2, FOV = 5 cm) to evaluate whether signs
of tissue damage were present after the exposures. After
all sonications, a bolus injection of MR contrast agent (0.1
mmol/kg, Omniscan, GE Healthcare), was administered,
followed by a saline flush, in order to visualize BBB disrup-
tion in the brain. Contrast-enhanced images were acquired
using a T1-weighted imaging sequence (FSE, TE = 14 ms,
TR = 500 ms, ETL = 4, BW = 15 kHz, 256 × 256/128 ×
128, slice = 1.5 mm, NEX = 3, FOV = 5 cm) to evaluate
the presence and extent of BBB opening.
Immunoblot analysis
Sonicated brain regions defined with trypan blue leak-
age, and their counterparts from opposite brain
hemispheres were isolated and homogenized in ice-cold
RIPA lysis buffer (containing 50 mM Tris-HCl pH 7.4,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF,
20 mM Na4P2O7,2m MN a 3VO4, 10% glycerol, 0.1%
SDS, 1% Triton-X-100, 0.5% Deoxycholate and protease
inhibitor cocktail). The homogenates were centrifuged
at 15,000 g for 30 min at 4°C and the protein concentra-
tion of the supernatants was determined using BCA™
protein assay kit. 30 μg of total protein was mixed with
3× SDS sample buffer (containing 240 mM Tris-Hcl pH
6.8, 6% SDS, 30% glycerol, 16% b-mercaptoethanol and
0.06% Bromphenol Blue), boiled at 100°C for 5 min and
resolved either in 10% or 7.5% SDS-PAGE gel. Separated
proteins were wet transferred to PVDF membrane,
blocked with 5% milk powder and consecutively incu-
bated with primary antibodies overnight at 4°C and
HRP-conjugated secondary antibodies 1 hour at room
temperature. Protein signals were detected using Super-
signal® West Pico Chemiluminescent Substrate (Thermo
Scientific) and the intensity of the bands was quantified
using GeneSnap from SynGene software. Primary anti-
bodies were: rabbit polyclonal anti-ZO-1 (Invitrogen,
5:1000), rabbit polyclonal anti-occludin (Invitrogen,
5:1000), mouse monoclonal anti-actin (Sigma), rabbit
monoclonal anti-phospho-Akt (ser473), rabbit monoclo-
nal anti-phospho-Akt (Thr308), rabbit monoclonal anti-
Akt, rabbit monoclonal anti-phospho-GSK3b (ser9),
rabbit monoclonal anti-phospho-p44/42 MAPK
(Thr202/Tyr204), rabbit monoclonal anti-phospho-p44/
42 MAPK, rabbit monoclonal anti-phospho-SAPK/JNK
(Thr183/Tyr185), rabbit monoclonal anti-SAPK/JNK (all
from Cell Signaling, 1:1000).
Immunoprecipitation
Brain tissues were homogenized in ice-cold Immunopre-
cipitation (IP) buffer (containing 50 mM Tris-HCl pH
7.5, 150 mM NaCl, 2 mM EDTA, 10% glycerol, 10 mM
sodium pyrophosphate, 10 mM b-glycerophosphate, 10
mM NaF, 1 mM sodium vanadate, 1% Nonidet p-40 and
protease inhibitor cocktail). The homogenates were cen-
trifuged at 15,000 g for 30 min in cold room and the
supernatants were collected and subjected to protein
assay as described in the previous section. For immuno-
precipitation, supernatants containing 1 mg total protein
in 500 μl IP buffer were first precleared with protein A
Sepharose beads (GE Health care) for 1 hour and then
incubated with 5 μg rabbit anti-occludin antibody (Invi-
trogen) overnight at 4°C, while constantly shaking on a
rotator. The samples were then incubated with protein
A Sepharose beads for 4 hrs at 4°C, and the formed
immunocomplexes (protein+primary antibody+beads)
were precipitated using centrifugation at 250 g for
1 min. The precipitates were washed three times with IP
buffer, mixed with 3× SDS sample buffer, boiled for
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explained previously.
Immunofluorescence Staining
For immunofluorescence staining of the brain sections,
rats were transcardially perfused with ice-cold PBS and
4% paraformaldehyde. Perfusion was performed using a
pump at a rate of 2.5 ml/min and the procedures
included: 1) Clamping of abdominal aorta 2) Insertion
of the perfusion syringe into the aorta through left ven-
tricle 3) Drainage of the solutions through right atrium.
After perfusion, the rats were decapitated and the brains
were removed from the skulls. The brains were subse-
quently post-fixed in 4% paraformaldehyde for 24 hours
followed by cryoprotection in 30% sucrose at 4°C over-
night. The brain tissues were then paraffin-embedded
using standard histological procedures and 7 μM-thick
sections were prepared and adhered to VWR® micro
slides (Superfrost® Plus). Immunofluorescence staining
with specific antibodies was performed according to
manufacturer’s instruction. Briefly, sections were depar-
affinized with xylene and then rehydrated with 100%
and 95% ethanol respectively. After washing with dH2O,
the antigens were unmasked by incubation of the sec-
tions at 10 mM sodium citrate buffer (pH 6) and heat-
ing them just below the boiling temperature (95-99°C)
for 20 min. The slides were then cooled down at room
temperature for 30 min, rinsed in dH2Oa n dP B S
respectively and then followed with immunostaining.
The sections were blocked with blocking buffer (PBS/
0.3% Triton-X-100/5% goat serum) for an hour at room
temperature and then incubated with primary antibodies
diluted with antibody dilution buffer (PBS/0.3% Triton-
X-100/1% BSA) overnight at 4°C. After washing sections
with PBS, they were incubated with Cy3-conjugated sec-
ondary antibody (Jackson ImmunoResearch Labora-
tories, 1:100) for 1 hour at dark and room temperature.
Sections were then washed and covered with vectashield
mounting medium containing DAPI and cover slips.
The primary antibodies were: rabbit anti-phospho-Akt
(Ser 473) (Cell signaling, 1:50), rabbit anti-phospho-
GSK3b (ser9) (cell signaling, 1:100), Alexa Fluor® 488-
conjugated Glial Fibrillary Acidic Protein (GFAP) mouse
monoclonal antibody (Cell signaling, 1:100), Alexa
Fluor® 488-conjugated Neuronal Nuclei (NeuN) mouse
monoclonal antibody (Millipore, 1:100), rabbit anti-ZO-
1 (Invitrogen, 1:100) and rabbit anti-Von Willebrand
Factor (vWF) (Abcam, 1:500). The final fluorescent
images were captured using ZEISS Axiovision 200 fluor-
escence microscope.
Statistical Analysis
Statistical comparison between two groups was analyzed
using ANOVA with Student t-test. The results were
expressed as mean ± SE. P value of < 0.05 was statisti-
cally considered significant.
Results
Extravasation of IgG and enhancement of MRI
contrast agent
Application of focused ultrasound (Figure 1) in the pre-
sence of ultrasound contrast agent (microbubbles)
increases the permeability of the BBB, the effect of
which is shown by enhancement of MRI contrast agent
(Figure 2A, arrow). To further determine the areas of
leaky vessels, we examined the presence of extravasated
blood components, such as IgG, in the regions of brain
treated with ultrasound (+US). Immunofluorescence
staining of non-sonicated brain tissue sections with cy3-
conjgated anti-rat IgG antibody show no staining (Figure
2B, -US). While sections taken from sonicated regions
show extensive staining for extravasated IgG (Figure 2C,
+US, arrow).
Diminished interaction of Zo-1 with occludin in response
to ultrasound
The extracellular domains of occludin form homotypic
interactions with adjacent cells. The intracellular portion
of occludin interacts with the intracellular scaffolding
proteins ZO-1 and ZO-2, providing a link to the cytos-
keletal protein actin, which establishes the tight junction
structure. A recent study by Sheikov et al [15] showed
that application of focused ultrasound in the presence of
ultrasound contrast agent resulted in increased paracel-
lular permeability in brain vascular endothelium.
Figure 1 Experiment set-up. Anesthetized rats are placed on their
backs with their heads on a water bag, which is placed above the
ultrasound transducer. A MRI coil surrounds the head of the rat
allowing for real-time imaging of the break-down of the blood
brain barrier.
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this effect is associated with delocalization as well as
diminished immunogold signals of tight junctional pro-
teins, including occludin, claudin 5 and ZO-1 [15]. Wes-
tern blot analysis with brain tissue homogenates show
that the protein levels of the tight junction proteins ZO-
1 and occludin in the ultrasound treated region is not
changed compared to non-treated regions (Figure 3A).
However, using immunoprecipitation analysis we show
that the interaction of occludin and ZO-1 is reduced in
the brain regions treated with ultrasound (Figure 3B).
Focused ultrasound treatment in the presence of
ultrasound contrast agent, increases PI3 kinase/Akt
signaling activity, while the activity of MAPK signaling
pathways remains unaffected
PI3kinase/Akt signaling has been shown to be responsi-
ble for both vascular permeability and neuronal survival
[23]. In addition, both in vivo and in vitro studies have
suggested a role for the MAPK kinase signaling pathway
in controlling the permeability of the BBB [18-21]. We
investigated the potential modulation of Akt and MAPK
signaling activity. We show that phosphorylation of Akt
at both serine (S473) and threonine (T308) residues is
increased in the sonicated brain, while the total Akt pro-
tein level remains unchanged (Figure 4A). Moreover, the
downstream signaling molecule of Akt, GSK3b, is highly
phosphorylated, further indicating the activation of Akt
signaling pathway in response to ultrasound treatment
(Figure 4A). Quantification of western blot band densi-
ties indicates that this increase is significantly (P < 0.05)
higher in the sonicated rat brain areas as compared to
non-treated contralateral regions (Figure 4C). The
increased phosphorylation of Akt and GSK3b is also
observed after 24-hours post-sonication (Figure 4B). In
contrast, there is no alteration at both phosphorylated
and non-phosphorylated levels of MAPK signaling mole-
cules (Figure 4A and 4B).
Increased p-Akt and pGSK3b localizes to neuronal cells
flanking the disrupted BBB
Ultrasound-mediated disruption of the BBB is associated
with increased phosphorylation of Akt and its down-
stream signaling molecule GSK3b a ss h o w ni nF i g u r e
4A and Figure 4B. The elevated pAkt and pGSK3b levels
extend until 24 hours post-sonication, when the
Figure 2 Increased leakage of MRI contrast agent and IgG into the brain parenchyma as a result of ultrasound-mediated Blood Brain
Barrier (BBB) disruption. A, MRI image shows enhancement of the MRI contrast agent in the right hemisphere of the brain (+US) shortly upon
exposure to ultrasound in the presence of microbubbles (green color, arrow). B, Immunofluorescence staining using cy3-conjugated anti-rat IgG
shows IgG extravasation into the brain parenchyma as a result of BBB opening (+US, arrow). DAPI represents nuclei of the cells (arrow heads).
‘-US’: refers to left hemisphere without ultrasound exposure. ‘+US’: refers to right hemisphere with ultrasound exposure and disrupted BBB.
Figure 3 Diminished interaction of ZO-1 and occludin as a result of ultrasound treatment. Rat brain homogenates were prepared from
both non-sonicated (-US) and sonicated (+US) regions. A, Western Blot analysis on whole brain tissue lysates (WTL) shows that ZO-1 and
occludin protein levels are not changed in response to ultrasound treatment. B, Co-immunoprecipitation of occludin and ZO-1. The amount of
Occludin co-precipitating with ZO-1 in the presence of US-treatment is reduced when compared to non-sonicated brains (-US).
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To investigate the origin of the cell types with increased
Akt activity, paraffin sections of brain tissues were
immuono-labelled with either pAkt or pGSK3b together
with either neuronal (NeuN) or astrocyte marker
(GFAP). The morphology of the cells is illustrated with
single staining of either GFAP (Figure 5A [ii]) and
NeuN (Figure 5B [i, ii]). Cells with increased pAkt
(Figure 5A [iv] and Figure 5B [iii, iv]) and pGSK3b (Fig-
ure 5A [vi] and Figure 5B [v,vi]) are shown in sonicated
brain areas. Fluorescent co-staining shows that the
increased pAkt and pGSK3b are localized to neuronal
cells of sonicated brain areas (Figure 5B [iii, iv, v, vi]).
Figure 5B [iv, vi] displays the neuronal cells and their
nearby extravasated IgGs, where there is an increased
BBB permeability.
Figure 4 Ultrasound in the presence of microbubbles increases the activity of the Akt signalling pathway, while the activity of MAPK
signalling remains unchanged. Brains were removed 1.5 hrs (A) or 24 hours (B) post-sonication and snap-frozen using liquid nitrogen. Brain
tissue regions with trypan blue leakage in the sonicated hemisphere (+US) and the equivalent area from opposite hemisphere (-US) were then
homogenized with RIPA lysis buffer. Equal amounts of extracted proteins were analyzed by western blotting for the indicated proteins. C,
Graphical representation of three independent experiments illustrating the marked increase in pAkt (Ser473), pAkt (Thre308) and pGSK3b (Ser9)
1.5 hrs after sonication treatment. The final data were analyzed with student’s t-test. Error bars indicate mean ± SE and the star (*) represents
p < 0.05 for -US versus +US.
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Page 6 of 10Figure 5 Increased phosphorylation of Akt and GSK3b in neuronal cells of sonicated rat brain regions. Paraffin sections of rat brains
were immunofluorescently stained with primary antibodies against astrocyte marker, Glial Fibrillary Protein (GFAP, green), Neuronal marker
(NeuN, green), phospho-Akt (pAkt, red) and phospho-GSK3 b (pGSK3b, red). In all sections, DAPI (blue) represents nuclear staining of the cells.
A, Panel [i] shows a control section without application of any primary antibodies. Panel [ii] represents a direct staining of the astrocytes with
Alexa-fluor488-conjugated GFAP (green, right arrow). Panels [iii] and [iv] represent immunofluorescence staining with pAkt (red, curved arrow)
and GFAP (green, right arrow) in non-sonicated (-US) as well as sonicated (+US) hemispheres respectively. Panels [v] and [vi] illustrate co-staining
of pGSK3b (red, pentagon) and GFAP (green, right arrow) in ‘-US’ and ‘+US’ brain regions respectively. B, Panels [ii] and [iii] represent neuronal
cells morphology as directly stained with Alexa-Fluor 488-conjugated NeuN (green, lightning bolt). Co-staining of pAkt (red, curved arrow) with
NeuN (green) and also pGSK3b (red, pentagon) with NeuN (green) are shown in panels [iii, iv] and [v, vi] respectively. The regions of the brain
sections with IgG extravasation (arrow head) and their surrounding neuronal cells with elevated levels of pAkt and pGSK3b are shown in panels
[iv, vi].
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The BBB restricts the free passage of the macromole-
cules from peripheral circulation to the central nervous
system and consists of the endothelial cells adhered to
one another via elaborate tight junction structures. The
physiological properties of the BBB are highly regulated
b yaw i d ev a r i e t yo ft h es i g n a ls originating either from
luminal (blood) or abluminal (astrocytes, pericytes, neu-
rons) face of the brain microvessel endothelial cells
[1,33-35]. While being inherently important, the normal
barrier function of the BBB is challenging when dealing
with brain delivery of therapeutic agents and requires
strategies to temporarily increase the permeability of the
brain endothelial cells. Recently, it has been shown that
focused ultrasound in the presence of circulatory micro-
bubbles (ultrasound contrast agent) is able to locally
and temporarily disrupt the BBB, providing a potential
and promising method for drug delivery [11,12,15]. In
the present study, the immunofluorescence staining of
rat IgG in the sonicated brain areas further confirms the
increased permeability of endothelial cells and disrup-
tion of the BBB.
Focused ultrasound-mediated increase in paracellular
permeability has been described as one of the entry
routes of macromolecules into the brain and immuno-
gold electron microscopy studies have shown that this
increase is associated with disarrangement and reduced
immunogold signals of tight junction proteins including
occludin, claudin 5 and ZO-1 [15]. The diminished level
of immunogold signals at the junction could be due to
degradation or the intracellular redistribution of tight
junction proteins. Here we show that the protein levels
of occludin and ZO-1 are not altered, but instead their
interaction is considerably reduced in the sonicated
brain areas, suggesting that the decrease in immunogold
signals may be the consequence of the redistribution of
tight junction proteins. The interaction of occludin and
ZO-1 is required for proper functioning of the tight
junctions and is also subject to tight regulation by sev-
eral mechanisms [1,35]. It has been shown that the
post-translational modifications play an essential role in
controlling the interaction of occludin and ZO-1. There
are several reports indicating that the phosphorylation
of occludin at tyrosine residues (Tyr-398 and Tyr-402)
decreases the interaction of this protein with ZO-1, ZO-
2 and ZO-3, thus enhancing the permeability of the
blood vessels [36,37]. Increased phosphorylation of
occludin at tyrosine residue is shown in a focal cerebral
ischemia model of the BBB disruption, further support-
ing a role for tight junction protein phosphorylation in
regulating the permeability of blood vessels [38]. Occlu-
din can also become phosphorylated on serine and
threonine (ser/thre) residues, but the effect of this phos-
phorylation event is distinct from that of tyrosine
residue. In fact, elevated ser/thre phosphorylation of
occludin promotes the assembly of the tight junctions,
resulting in a reduction in permeable vessels [39]. Given
that the phosphorylation of the proteins is an immediate
event and the disruption of the BBB also occurs shortly
after sonication, it is plausible that the ultrasound-
mediated diminished interaction of occludin and ZO-1
is due to alteration in phosphorylation level of tight
junction proteins.
The synthesis, assembly and function of tight junction
proteins and their ultimate effect on BBB opening, could
be influenced by several signaling molecules. For
instance, Rho signaling, Myosine Light Chain Kinase
( M L C K ) ,P K C ,P K A ,P K G ,p h o s p h a t a s e s( P P 1 ,P P 2 A
and PP2B), MAPK and PI3kinase/Akt pathways are
shown to be implicated in the regulation of tight junc-
tion function and vessel leakage [33]. In this study we
investigated a role for PI3 kinase/Akt and MAPK signal-
ing in response to focused ultrasound-mediated BBB
disruption. The PI3kinase/Akt signaling pathway is
shown to be activated by a number of cell-membrane
located receptors (G-protein-coupled receptors and tyro-
sine kinases) and plays an important role in the survival
of both endothelial and neuronal cells [40]. Both in vivo
and in vitro studies suggest that the increased Akt activ-
ity is involved in hyperpermeability of the BBB
[16,17,23]. Furthermore, ultrasound application is
known to produce shear stress [41]. Given that shear
stress also triggers the activation of Akt in vascular
endothelial cells [42], we might assume that ultrasound
treatment triggers activation of Akt, leading to increased
permeability of the endothelial cells. In addition, active
Akt can phosphorylate endothelial nitric oxide synthase
(eNOS), the activity of which increases NO production
and the BBB permeability [43]. In the current study we
show that both Akt and GSK3b phosphorylation are
increased in the ultrasound-received brain regions,
implying that increased Akt activity might contribute to
the BBB opening. However, increased phosphorylation
of Akt is also evident 24 hours after sonication, the time
window that the tight junction proteins are re-
assembled and the BBB function is restored.
Our immunofluorescence staining localizes increased
pAkt and pGSK3b levels into neuronal cells of the BBB-
disrupted brain areas, implying that ultrasound
application results in the activation of survival pathways
in neuronal cells. This observation is in accordance with
a previous report indicating that in a cerebral ischemia
model of the BBB disruption, the increased PI3kinase/
Akt signaling promotes neuronal survival [22]. Akt is a
downstream signaling molecule of tyrosine kinase recep-
tors and is activated upon binding of these receptors to
their cognate ligand molecul e s[ 4 0 ] .V E G Fi so n eo ft h e
signaling molecules that binds to its receptors on cell
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Page 8 of 10membrane, VEGFR1 and VEGFR2, initiating signaling
pathways through Akt activation. Transgenic animals
expressing human VEGF165 under a neuron-specific pro-
moter, as well as intracerebroventricular administration
of VEGF both are shown to increase Akt activity and
enhance neuronal survival after focal cerebral ischemia
[23,44]. It is plausible that the ultrasound-mediated
increase of neuronal Akt activity is the result of VEGF
action. In addition to VEGF, there might be other factors
which could induce the elevation of Akt in neuronal
cells. For instance, the extravasation of blood compo-
nents into the brain can initiate several signaling path-
ways in the neuronal and glial cells. As a result of the
BBB disruption, fibrinogen is shown to enter the brain
parenchyma, where it binds and induces the phosphory-
lation of epidermal growth factor receptor (EGFR) in an
integrin- and src-dependent manner [45]. Given that tyr-
osine kinase EGFR is upstream signaling molecule of
Akt, it is possible that extravasated fibrinogen turns on
the activity of Akt in the sonicated brain regions.
Conclusions
Our data provides evidence that focused ultrasound in
the presence of circulating ultrasound contrast agents
(microbubbles) disrupts the interaction of tight junction
proteins (occludin and ZO-1), thus affecting the integ-
rity of the BBB. Application of ultrasound results in acti-
vation of PI3kinase/Akt signaling pathway in neuronal
cells.
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